Can Biotech Duplicate Its 2014 Performance, or Is It Time to Jump Ship?
Although biotech stocks as a whole handily outpaced the S&P 500 returns last year, there’s no guarantee that investors will be similarly rewarded this year. To get insight into whether biotech stocks can continue climbing, we asked three top Motley Fool contributors to give us their opinion. Read on to learn what they think.: Bringing a new drug to market […]